Synthesis and characterization of 5,6,7,8-tetrahydroquinoline C5a receptor antagonists
作者:J. Kent Barbay、Yong Gong、Mieke Buntinx、Jian Li、Concha Claes、Pamela J. Hornby、Guy Van Lommen、Jean Van Wauwe、Wei He
DOI:10.1016/j.bmcl.2008.03.049
日期:2008.4
A novel series of substituted 2-aryl-5-amino-5,6,7,8-tetrahydroquinoline C5a receptor antagonists is reported. Synthetic routes were developed that allow the substituents on the tetrahydroquinoline core to be efficiently varied, facilitating determination of structure-activity relationships. Members of the series display high binding affinity for the C5a receptor and are potent functional antagonists. (c) 2008 Elsevier Ltd. All rights reserved.
Terenin, V. I.; Afanas'eva, T. A.; Kurts, A. L., Journal of Organic Chemistry USSR (English Translation), 1992, vol. 28, # 4.2, p. 642 - 646
作者:Terenin, V. I.、Afanas'eva, T. A.、Kurts, A. L.、Bundel', Yu. G.
DOI:——
日期:——
Recyclization of methoxy-substituted 1,2-dimethylisoqunolinium salts
作者:V. I. Terenin、T. A. Afanas'eva、A. N. Kurts、Yu. G. Bundel'
DOI:10.1007/bf00472528
日期:1991.6
The 3-D conformational shape of N-naphthyl-cyclopenta[d]pyrimidines affects their potency as microtubule targeting agents and their antitumor activity
作者:Weiguo Xiang、Tasdique M. Quadery、Ernest Hamel、Lerin R. Luckett-Chastain、Michael A. Ihnat、Susan L. Mooberry、Aleem Gangjee
DOI:10.1016/j.bmc.2020.115887
日期:2021.1
substituted cyclopenta[d]pyrimidine compounds, 4–10, were designed and synthesized to study the influence of the 3-D conformation on microtubule depolymerizing and antiproliferative activities. NOESY studies with the N,2-dimethyl-N-(6ʹ-methoxynaphthyl-1ʹ-amino)-cyclopenta[d]pyrimidin-4-amine (4) showed hindered rotation of the naphthyl ring around the cyclopenta[d]pyrimidine scaffold. In contrast, NOESY
设计并合成了一系列甲氧基萘基取代的环戊[ d ]嘧啶化合物4-10 ,以研究3-D构象对微管解聚和抗增殖活性的影响。 NOESY 对N ,2-二甲基-N- (6ʹ-甲氧基萘基-1ʹ-氨基)-环戊[ d ]嘧啶-4-胺 ( 4 ) 的研究表明萘环围绕环戊[ d ]嘧啶支架的旋转受到阻碍。相比之下,NOESY 对N ,2-二甲基-N- (5ʹ-甲氧基萘基-2ʹ-氨基)-环戊[ d ]嘧啶-4-胺 ( 5 ) 的研究表明,萘环围绕环戊[ d ]嘧啶自由旋转脚手架。 4和5之间的旋转灵活性和构象差异导致生物活性的显着差异。化合物4没有活性,而5是该系列中最有效的化合物,具有有效的微管解聚作用,并且在体外针对多种癌细胞系具有低纳摩尔 IC 50值。在 U251 神经胶质瘤异种移植模型中研究了5抑制体内肿瘤生长的能力。结果表明, 5比阳性对照替莫唑胺具有更好的抗肿瘤作用,并确定5作为进一步研究的潜在临床前候选药物。